Clinical Trial Update: Combination Therapy for Neovascular Age Related Macular Degeneration [NA]

View source ↗

Summary

A Yonsei University-sponsored clinical trial investigating a combination therapy for neovascular age-related macular degeneration has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Snippet

Sponsor: Yonsei University | Conditions: Macular Degeneration | NA | Status: WITHDRAWN